Search This Blog

Monday, November 11, 2019

Analyst action, Nov. 11

AcelRx Pharmaceuticals (NASDAQ:ACRX) downgraded to Neutral with a $2 (3% upside) price target at Credit Suisse. Shares down 3% premarket.
CytomX Therapeutics (NASDAQ:CTMX) downgraded to Neutral with an $8 (34% upside) price target at Wedbush. Shares down a fraction premarket.
Wright Medical Group (NASDAQ:WMGI) downgraded to Neutral with a $31 (5% upside) price target at Baird.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)